Total Payments
$9,084
2024 Payments
$1,159
Companies
50
Transactions
411
Medicare Patients
12,343
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$7,905 (87.0%)
Consulting$1,138 (12.5%)
Education$41.76 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,905 | 406 | 87.0% |
| Consulting Fee | $1,138 | 1 | 12.5% |
| Education | $41.76 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,407 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $988.58 | 69 | $0 (2022) |
| Lilly USA, LLC | $416.51 | 23 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $399.53 | 16 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $385.79 | 6 | $0 (2022) |
| PFIZER INC. | $350.40 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $331.05 | 21 | $0 (2020) |
| Allergan, Inc. | $325.74 | 13 | $0 (2020) |
| Astellas Pharma US Inc | $321.58 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $266.79 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,159 | 44 | Teva Pharmaceuticals USA, Inc. ($187.99) |
| 2023 | $1,106 | 55 | Sumitomo Pharma America, Inc. ($166.49) |
| 2022 | $1,872 | 39 | Novartis Pharmaceuticals Corporation ($1,181) |
| 2021 | $712.69 | 37 | AstraZeneca Pharmaceuticals LP ($149.32) |
| 2020 | $745.24 | 43 | Sunovion Pharmaceuticals Inc. ($118.60) |
| 2019 | $920.12 | 50 | Janssen Pharmaceuticals, Inc ($169.61) |
| 2018 | $1,049 | 59 | Janssen Pharmaceuticals, Inc ($241.02) |
| 2017 | $1,520 | 84 | Janssen Pharmaceuticals, Inc ($450.01) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.21 | General |
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Biological | ||||||
| 08/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Biological | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Biological | ||||||
| 07/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $97.79 | General |
| Category: Central Nervous System | ||||||
| 07/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 06/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Allergy/Immunology | ||||||
| 06/10/2024 | Silk Road Medical, Inc. | ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter (Device), ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Biological | ||||||
| 05/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Central Nervous System | ||||||
| 05/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $97.79 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 3,560 | 6,139 | $555,531 | $357,252 |
| 2022 | 37 | 2,908 | 5,441 | $509,544 | $295,583 |
| 2021 | 32 | 2,779 | 5,438 | $507,184 | $299,212 |
| 2020 | 40 | 3,096 | 5,922 | $522,726 | $311,003 |
Total Patients
12,343
Total Services
22,940
Medicare Billing
$1.3M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 249 | 1,027 | $119,132 | $85,299 | 71.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 593 | $82,427 | $52,308 | 63.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 207 | 236 | $62,540 | $33,586 | 53.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 74 | 74 | $27,477 | $20,920 | 76.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 160 | 160 | $26,720 | $20,117 | 75.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 358 | $27,566 | $17,142 | 62.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 50 | 59 | $20,833 | $12,082 | 58.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 148 | 149 | $14,913 | $11,285 | 75.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 79 | 168 | $18,144 | $9,584 | 52.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 61 | 61 | $10,370 | $7,837 | 75.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 62 | 89 | $10,324 | $7,285 | 70.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 42 | 102 | $9,078 | $5,954 | 65.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 36 | 43 | $7,439 | $5,167 | 69.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 146 | 147 | $5,145 | $4,445 | 86.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 69 | $6,555 | $4,434 | 67.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 155 | 300 | $7,800 | $4,408 | 56.5% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 73 | 134 | $9,648 | $4,404 | 45.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 28 | 96 | $7,488 | $3,541 | 47.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 91 | $5,278 | $3,321 | 62.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 133 | 200 | $6,200 | $3,292 | 53.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 42 | 59 | $5,251 | $3,269 | 62.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 169 | 169 | $3,887 | $2,991 | 77.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 139 | 227 | $5,675 | $2,978 | 52.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 73 | $4,818 | $2,736 | 56.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 157 | 250 | $5,000 | $2,588 | 51.7% |
About Dr. Adrian Burrowes, MD
Dr. Adrian Burrowes, MD is a Family Medicine healthcare provider based in Casselberry, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700822657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Burrowes, MD has received a total of $9,084 in payments from pharmaceutical and medical device companies, with $1,159 received in 2024. These payments were reported across 411 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,905).
As a Medicare-enrolled provider, Burrowes has provided services to 12,343 Medicare beneficiaries, totaling 22,940 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Casselberry, FL
- Active Since 06/21/2006
- Last Updated 06/04/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700822657
Products in Payments
- ENTRESTO (Drug) $1,386
- XARELTO (Drug) $782.40
- NUPLAZID (Drug) $385.79
- REXULTI (Drug) $361.53
- TRULICITY (Drug) $334.49
- Austedo XR (Drug) $252.56
- Epclusa (Drug) $231.21
- GEMTESA (Drug) $230.00
- NUEDEXTA (Drug) $212.63
- INVOKANA (Drug) $206.18
- XIFAXAN (Drug) $180.93
- LOKELMA (Drug) $175.64
- VRAYLAR (Drug) $174.92
- Leqembi (Drug) $166.35
- Kerendia (Drug) $163.42
- Veozah (Drug) $159.11
- EVENITY (Biological) $134.28
- NAMZARIC (Drug) $116.54
- Vascepa (Drug) $111.25
- AUSTEDO (Drug) $106.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Casselberry
Jeaudine Hill, M.d, M.D
Family Medicine — Payments: $51,791
Family Medicine $51,791
Dr. Venkatesh Nagalapadi, M.d, M.D
Family Medicine — Payments: $41,731
Family Medicine $41,731
Dr. Steven Selznick, D.o, D.O
Family Medicine — Payments: $33,752
Family Medicine $33,752
Dr. Akila Balasubramanian, Md, MD
Family Medicine — Payments: $6,832
Family Medicine $6,832
Roberteen Mccray, Do, DO
Family Medicine — Payments: $1,984
Family Medicine $1,984
Dr. Morteza Mashkouri, M.d, M.D
Family Medicine — Payments: $892.99
Family Medicine $892.99